{"name":"Eyetech Pharmaceuticals","slug":"eyetech-pharmaceuticals","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxNcEJ4dmVQdlRZVEs1UE5zbkdBaUZ2TW14X0dFajlXVDBNeXVPa3VTV3o5QjJtcF83d3cwWXZIQ3dtTjVqeFlsMWdHUHp0N0lpd25YQkgwVFl5WlV0d1RrZldYRDBPdHg1OERHVXlHWDhUTXp5aVBVbXlNN0JNN3NvaFQteUs1TnlBN0ZwZ0VncWVkZw?oc=5","date":"2026-01-22","type":"pipeline","source":"pharmaphorum","summary":"Changing Faces: Board appointments, November and December 2025 - pharmaphorum","headline":"Changing Faces: Board appointments, November and December 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE1jRGR5WU9kaUdERGo4eGJwM3VEUHhVdlpfbnM2Z2s4VHdrdUpET0xraTNuYkI4WE1LV0NMLU5zdm56a05zUWhpemEtWVgzUDR0VjRqTjFhY2JDZTYxc1JJSmtWVFRfUko2WUlUSENXUjdjczV3NGdhTFRCWQ?oc=5","date":"2025-07-30","type":"deal","source":"Health Tech World","summary":"German pharma signs US$1bn eye tech deal - Health Tech World","headline":"German pharma signs US$1bn eye tech deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgJBVV95cUxOYlE1bDB1YnJCNjQ0QVBTMWdxb1ZwXzhLTFQ5ZHhEbWxWbnF1U2g1OGFydDlWYW1Pb1I2WklXdzNXZkhSSmFCUGVEX3ZWemg3VmhoSXd6WlY3X3JqZHpLYnZGY3JQWVdKOEcybWQzRHhyamFDSDJBckcxYngyd3hTS1kza0RqbXR2SVR2dnkyOGZWQ0ZXVzV0bXpzcF9UenFvRmFVQnlZU3NuaHlEcG10SHY0Z0pxOG1rdjQ2WGpSZnAxYWFFQjBENkZwNHMxc190S1dNdGE2Y3ZlZ21fVWV2OTJtX2NSaEd5Vm1nLTBpMGpsRnRnVFVHNmRNVUZ5NkhvX2pXaXlDQ0wwckEwR2c?oc=5","date":"2025-04-09","type":"pipeline","source":"Business Wire","summary":"Aviceda Therapeutics Appoints Ophthalmology Innovator and Industry Leader Dr. Emmett T. Cunningham, Jr. to Board of Directors - Business Wire","headline":"Aviceda Therapeutics Appoints Ophthalmology Innovator and Industry Leader Dr. Emmett T. Cunningham, Jr. to Board of Dire","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxNWWZUTVVwVkN5T3R3VWxMb3hhYWdGZWZEOWZPSHpiYjNiM0RPcmQtRWI2ZHVjOFpaTWl0RDB6aHJGZDJuQnpmUE01WHcwZ1ZDZkVJZjBuWUZ5QTFVYzB5bk1QMkFSQ1JHcGttd3FGUnJhRnRuZVBVNmNTR0hyTVc4X3JuTTBKWnBjRlpha2xWbk1VUQ?oc=5","date":"2024-12-12","type":"pipeline","source":"The Pharma Letter","summary":"Tenpoint and Visus unite ahead of presbyopia drop filing - The Pharma Letter","headline":"Tenpoint and Visus unite ahead of presbyopia drop filing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxPTmxnRTJ2S0NyZTVwdXRETEs0cXFJTzlRbnZZSXMyMmhGYUNLSFh0Z0ZIYjVQQkhpNVNxRk9HNTNiRFppaGRvTXNkdFFEZGNPODFCR0pXRlZLMUZyY1hRYnZwS3pWbU5RNEdnT0Ryd3NwbWc3VnY2UElTNXBjdm9wNmhQY2J0MldmQjRLS1dTQjc4WUNjeURxNA?oc=5","date":"2024-05-29","type":"deal","source":"BioPharma Dive","summary":"Merck to buy eye drug developer for $1.3B - BioPharma Dive","headline":"Merck to buy eye drug developer for $1.3B","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxQcVYza2x0Qy1JdUZ4U0hUYVNCOW1NWW43YWV6elpjUE8yZ0F0WnRBNlVaWFgzUVYtQXFOYUFmNmJMQUxHWWN3Mkp6SGRUQUpTdmhHbnhPancwQU9VZDROT2JINmhmNU1qMjlsZDJ3aWpDYl9iWW1qZTB6dmE3SHkzbHBPQjFlcXdfcEdzRkREb1paZw?oc=5","date":"2024-05-29","type":"pipeline","source":"BioWorld News","summary":"Merck paying $1.3B up front for 3-year-old Eyebio - BioWorld News","headline":"Merck paying $1.3B up front for 3-year-old Eyebio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxOMnF4QmhHaFd5YXVKU2J0RmdxY0NYcTBRMmxEXzlRbUxGVjBCWldJb2dsLVNJQjdvT3VzREs1Z0dSMDdiQm5rOXZHa2g2SF9uem92WUprMnpDTzRWSjU0Q1kxU1Q0a2lDZGNfNDVBQnlZNThwcmtPRGVYY0hzY2NaMDA5cmlzM0xXMXNGWTRtYi1NdFRHeWc?oc=5","date":"2024-04-19","type":"pipeline","source":"Dallas Innovates","summary":"Opthalmic Industry Veteran Joins Nacuity Pharmaceuticals’ Board - Dallas Innovates","headline":"Opthalmic Industry Veteran Joins Nacuity Pharmaceuticals’ Board","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxPb3dUczFybjhtMHk1b0cwVFpPd3M5ZGFId3B3YWJMaEhzWllfUXh5ajdpNEo5WFNXOVY5X2p4VkJ6U3VOMDdvS1g1TDlYTmJyQ0trYmNhN3VkV1RZRGs4V3dqYWVDWWJxSVYwekJZZTg1Y3JwNmRQM3hrNmdfOGRNUHhwMzJBVzc1cEQ5MngzVXFQQnFrS1NTb2RUdTBaT3NPVld6WDhqaw?oc=5","date":"2023-08-22","type":"deal","source":"BioWorld News","summary":"Hengrui inks $1B out-licensing deal for asthma drug with One Bio - BioWorld News","headline":"Hengrui inks $1B out-licensing deal for asthma drug with One Bio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTE9iVlhGQ0lwTVVKSFZKR1VydTRRQ3RuYmVaQWVTRnJUODVJWjhSR3NvMXlBbWcxUHhqV3U3ZXpqeV9Od0ljdDdiQ2w0MDVzYWwxbFFubjdSaTRBQmlvckE?oc=5","date":"2022-05-11","type":"pipeline","source":"Pharmaceutical Executive","summary":"Challenging Assumptions - Pharmaceutical Executive","headline":"Challenging Assumptions","sentiment":"neutral"},{"date":"2006-02-14","type":"earnings","source":"SEC EDGAR","summary":"SC 13D filed with SEC: PFIZER INC. SCHEDULE 13D - EYETECH PHARMACEUTICALS INC.","headline":"SC 13D Filing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTE12QllmVm9LTTJlcllkNm9WUlV5Yzd4aXUzeWE4QzRDa3FySGltdHVETklNanB3dTc4SkpjcU5sREk4ZF9mMTRwWmgxVVhDR1Vkd2VVRjdHa3FVLXF5eVc0Rmwxdi1vU1c5enJkLWdHcnRiejRVblE?oc=5","date":"2005-08-29","type":"deal","source":"C&EN","summary":"OSI to Acquire Eyetech Pharma - C&EN","headline":"OSI to Acquire Eyetech Pharma - C&EN","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar","revenue":null,"revenuePeriod":null,"revenueHistory":[],"grossProfit":null,"grossProfitHistory":[],"rdSpend":null,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":null,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":null,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"ciks":null,"lastFiledAt":null},"yahoo":null}